311 related articles for article (PubMed ID: 23701182)
1. Update on hypophysitis and TTF-1 expressing sellar region masses.
Kleinschmidt-DeMasters BK; Lopes MB
Brain Pathol; 2013 Sep; 23(5):495-514. PubMed ID: 23701182
[TBL] [Abstract][Full Text] [Related]
2. Histological features of pituitary adenomas and sellar region masses.
Kleinschmidt-DeMasters BK
Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):476-484. PubMed ID: 27763894
[TBL] [Abstract][Full Text] [Related]
3. Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors.
Shibuya M
Brain Tumor Pathol; 2018 Apr; 35(2):62-70. PubMed ID: 29500747
[TBL] [Abstract][Full Text] [Related]
4. Sellar Tumors.
Schwetye KE; Dahiya SM
Surg Pathol Clin; 2020 Jun; 13(2):305-329. PubMed ID: 32389269
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma.
Wang J; Liu Z; Du J; Cui Y; Fang J; Xu L; Li G
Neuropathology; 2016 Oct; 36(5):432-440. PubMed ID: 26919073
[TBL] [Abstract][Full Text] [Related]
6. Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells.
Hagel C; Buslei R; Buchfelder M; Fahlbusch R; Bergmann M; Giese A; Flitsch J; Lüdecke DK; Glatzel M; Saeger W
Pituitary; 2017 Apr; 20(2):211-217. PubMed ID: 27744503
[TBL] [Abstract][Full Text] [Related]
7. TTF-1-positive oncocytic sellar tumor with follicle formation/ependymal differentiation: non-adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma.
Yoshimoto T; Takahashi-Fujigasaki J; Inoshita N; Fukuhara N; Nishioka H; Yamada S
Brain Tumor Pathol; 2015 Jul; 32(3):221-7. PubMed ID: 25893822
[TBL] [Abstract][Full Text] [Related]
8. [Space occupying processes of the sellar region with emphasis on tumor-like lesions].
Saeger W
Pathologe; 2003 Jul; 24(4):247-54. PubMed ID: 14513270
[TBL] [Abstract][Full Text] [Related]
9. Pituicytoma: Review of commonalities and distinguishing features among TTF-1 positive tumors of the central nervous system.
El Hussein S; Vincentelli C
Ann Diagn Pathol; 2017 Aug; 29():57-61. PubMed ID: 28807344
[TBL] [Abstract][Full Text] [Related]
10. What's new in pituitary pathology?
Asa SL; Mete O
Histopathology; 2018 Jan; 72(1):133-141. PubMed ID: 29239033
[TBL] [Abstract][Full Text] [Related]
11. Is spindle cell oncocytoma a true entity or a variant of pituicytoma? A case report with review of literature.
Gupta RK; Batra VV; Singh D; Sharma MC; Kumar V
Neurol India; 2018; 66(5):1413-1418. PubMed ID: 30233016
[TBL] [Abstract][Full Text] [Related]
12. HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis.
Heaney AP; Sumerel B; Rajalingam R; Bergsneider M; Yong WH; Liau LM
J Clin Endocrinol Metab; 2015 Nov; 100(11):4092-7. PubMed ID: 26317559
[TBL] [Abstract][Full Text] [Related]
13. Review of xanthomatous lesions of the sella.
Kleinschmidt-DeMasters BK; Lillehei KO; Hankinson TC
Brain Pathol; 2017 May; 27(3):377-395. PubMed ID: 28236350
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and clinical implications of pituicytoma.
Furtado SV; Ghosal N; Venkatesh PK; Gupta K; Hegde AS
J Clin Neurosci; 2010 Jul; 17(7):938-43. PubMed ID: 20403698
[TBL] [Abstract][Full Text] [Related]
15. Rare Thyroid Transcription Factor 1-Positive Tumors of the Sellar Region: Barrow Neurological Institute Retrospective Case Series.
Cole TS; Potla S; Sarris CE; Przybylowski CJ; Baranoski JF; Mooney MA; Barranco FD; White WL; Eschbacher JM; Little AS
World Neurosurg; 2019 Sep; 129():e294-e302. PubMed ID: 31132506
[TBL] [Abstract][Full Text] [Related]
16. Sellar lesion: not always a pituitary adenoma.
Rao S; Rajkumar A; Kuruvilla S
Indian J Pathol Microbiol; 2008; 51(2):269-70. PubMed ID: 18603706
[TBL] [Abstract][Full Text] [Related]
17. Xanthomatous Hypophysitis Is Associated with Ruptured Rathke's Cleft Cyst.
Duan K; Asa SL; Winer D; Gelareh Z; Gentili F; Mete O
Endocr Pathol; 2017 Mar; 28(1):83-90. PubMed ID: 28120170
[TBL] [Abstract][Full Text] [Related]
18. Multiple recurrences require long-term follow-up in patients diagnosed with spindle cell oncocytoma of the sella turcica.
Manoranjan B; Koziarz A; Kameda-Smith MM; Provias JP
J Clin Neurosci; 2017 Sep; 43():134-146. PubMed ID: 28668473
[TBL] [Abstract][Full Text] [Related]
19. Posterior pituitary tumours: the spectrum of a unique entity. A clinical and histological study of a large case series.
Guerrero-Pérez F; Vidal N; Marengo AP; Pozo CD; Blanco C; Rivero-Celada D; Díez JJ; Iglesias P; Picó A; Villabona C
Endocrine; 2019 Jan; 63(1):36-43. PubMed ID: 30276594
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of Pituitary Adenomas and Sellar Lesions.
Kobalka PJ; Huntoon K; Becker AP
Neurosurgery; 2021 Apr; 88(5):900-918. PubMed ID: 33476394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
